Skip to content
lifestyle.sourcefed.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Orchestra BioMed Holdings, Inc.
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
March 12, 2026
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
March 3, 2026
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
February 19, 2026
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 13, 2026
←
Previous Page
1
2